TrademarkDir
AMYLOIDOSISNEWS
LIVE

Serial Number

90706065

Owner

The Lynx Group, LLC

Attorney

Brian L. Petrequin, Esq.

First Use Date

Sep 1, 2020

Filing Date

May 12, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

AMYLOIDOSISNEWS Trademark

Serial Number: 90706065 • Registration: 6674312

AMYLOIDOSISNEWS is a trademark filed by The Lynx Group, LLC on May 12, 2021. The trademark is classified under Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

The Lynx Group, LLC

2050 Cabot Boulevard West, Suite 110
Langhorne, PA 19047

Entity Type: 16

Trademark Details

Filing Date

May 12, 2021

Registration Date

March 15, 2022

First Use Anywhere

September 1, 2020

First Use in Commerce

November 5, 2020

Goods & Services

Electronic downloadable publications, namely, journals, magazines, newsletters, feature reports, monographs and supplements of the foregoing in the fields of medicine, healthcare, well-being and nutrition

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 16, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 16, 2026 COAR
REGISTERED-SUPPLEMENTAL REGISTER
Mar 15, 2022 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 10, 2022 PREV
ASSIGNED TO LIE
Feb 10, 2022 ALIE
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Feb 8, 2022 CNTA
EXAMINER'S AMENDMENT ENTERED
Jan 28, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 28, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 28, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 28, 2022 CNEA
ASSIGNED TO EXAMINER
Jan 19, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2021 NWOS
NEW APPLICATION ENTERED
May 15, 2021 NWAP

Related Trademarks

More from this Owner

CONQUER: THE JOURNEY INFORMED

CONQUER: THE JOURNEY INFORMED

CONQUER: THE JOURNEY INFORMED

CONQUER: THE JOURNEY INFORMED

CONQUER: THE JOURNEY INFORMED

CONQUER: THE JOURNEY INFORMED

CONSIDERATIONS IN LYMPHOMA

CONSIDERATIONS IN LYMPHOMA

CONSIDERATIONS IN LYMPHOMA

CONSIDERATIONS IN LYMPHOMA

CONSIDERATIONS IN LYMPHOMA

CONSIDERATIONS IN LYMPHOMA